Medice Pütter, CC Nefro 200 Medice Pütter

Medice Pütter CC Nefro 200, is a medicinal product specially developed for patients with certain kidney diseases, they are intended to support kidney function and relieve certain symptoms and complications associated with kidney disease. composition – based on 1 pc. 500 mg calcium carbonate, 200 mg calcium ions, + Microcrystalline cellulose, Crospovidone, Hypromellose, Lactose 1-water, Macrogol 6000, Magnesium stearate (Ph. Eur.) [vegetable], Polyoxyethylene (8) monostearate, Povidone K30, Silicon dioxide, highly dispersed, talc, titanium dioxide. Contraindications. The medicine must not be taken – if you are allergic to calcium carbonate or any other ingredient of this medicine, if the calcium concentration in the blood is too high (hypercalcemia). Increased calcium concentration regularly occurs with increased activity of the parathyroid glands (hyperparathyroidism). It can also occur with an overdose of vitamin D; some tumors such as lung cancer (bronchial carcinoma), breast cancer (mammary carcinoma), kidney cancer (hypernephroma), some forms of blood cancer (plasmacytoma) and bone metastases, some lung diseases (sarcoidosis, Beck’s disease); immobilization of the limbs (immobilization osteoporosis), with a decrease in the serum phosphate content (hypophosphatemia), with calcium-containing kidney stones, in the absence of free hydrochloric acid in the gastric juice. Film-coated tablets should be taken whole, if possible with a small amount of liquid, immediately before or during meals. Always take this medicine exactly as described or as your doctor or pharmacist has told you. The dosage depends on the serum phosphate level. Recommended dose: Adult – The dosage is always determined after consultation with your doctor. When determining individual and daily doses, the phosphate content and the number of meals must be taken into account. The dosage range is 1 to 3 tablets 3 times a day, for example, 1 tablet during breakfast, 3 tablets during lunch and 2 tablets during dinner. The maximum dose of 7 tablets (corresponding to 1400 mg of calcium) should not be exceeded. Children and adolescents (under 18 years): its use cannot be recommended for these patients. Duration of use: Therapy with a phosphate binder in patients with chronic renal failure is long-term and requires regular medical supervision. Calcium overdose can lead to high calcium levels in the blood (hypercalcemia). If you accidentally take too many tablets, consult a doctor. Overdose symptoms may include muscle weakness, abdominal pain, constipation, nausea, vomiting, extreme thirst, abnormal heart rhythm, and loss of consciousness. If you forget to take a dose, do not take a double dose to make up for the missed dose. Instead, continue taking the prescribed dose. Never take the medicine after meals. Side effects – Feeling of fullness caused by the release of carbon dioxide gas by stomach acid. Decreased absorption of phosphate due to the formation of sparingly soluble salts, increased calcium concentration in the blood (hypercalcemia), increased excretion of calcium in the urine (hypercalciuria), hypoacidity of the blood (metabolic alkalosis), calcification of soft tissues and blood vessels. If the calcium level in the blood is elevated, the dose should be reduced. In patients on dialysis, the calcium content in the dialysis fluid may also temporarily decrease. There are no reports of harmful effects of calcium during pregnancy and breastfeeding in humans. Serum calcium levels should be closely monitored during pregnancy, as prolonged hypercalcemia may result in physical malformations and mental retardation in the child.